Antimicrobial proteins from oyster hemolymph improve the efficacy of conventional antibiotics
PLOS ONE · 21.01.2025 · 20 (1) · e0312305
DOI: 10.1371/journal.pone.0312305 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 21.01.2025. Verfasst von Kate Summer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science and Engineering, Southern Cross University, Lismore, NSW, Australia. Hauptthemen laut MEDLINE: Hemolymph, Anti-Bacterial Agents, Ostreidae, Antimicrobial Peptides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Southern Cross University, Malacological Society of Australasia, Australian Research Council.
Abstract (Originalsprache)
Discovering new antibiotics and increasing the efficacy of existing antibiotics are priorities to address antimicrobial resistance. Antimicrobial proteins and peptides (AMPPs) are considered among the most promising antibiotic alternatives and complementary therapies. Here, we build upon previous work investigating the antibacterial activity of a semi-purified hemolymph protein extract (HPE) of the Australian oyster Saccostrea glomerata . HPE showed antimicrobial-biofilm inhibitory activity toward laboratory and clinical strains of Streptococcus pneumoniae and Streptococcus pyogenes at 4.4 and 24.1 μg/mL total protein, respectively. In combination assays, the effectiveness of conventional antibiotics (ampicillin, gentamicin, trimethoprim and ciprofloxacin) was improved between 2 to 32-fold in the presence of HPE (1–12 μg/mL) against a range of clinically important bacteria including Streptococcus spp., Pseudomonas aeruginosa , Moraxella catarrhalis , Klebsiella pneumoniae and Staphylococcus aureus . Effective HPE concentrations are comparable to AMPPs currently approved for use or in clinical trials pipelines. Proteomics analysis of HPE identified a number of proteins including abundant known AMPPs. It was non-toxic to A549 human lung cells up to 205 μg/mL, demonstrating safety well above effective concentrations. Activity was retained with storage at -80°C and ambient laboratory temperature (~24°C), but declined after treatment at either 37°C or 60°C (1 h). This study is in agreement with growing evidence that AMPPs show specificity and a high capacity for synergism with antibiotics. The discovery of HPE provides great opportunities for both pharmaceutical and aquaculture industry development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Science and Engineering, Southern Cross University, Lismore, NSW, Australia.
- Flinders Accelerator for Microbiome Exploration, College of Science and Engineering, Flinders University, Bedford Park, SA, Australia.
- National Marine Science Centre, Southern Cross University, Coffs Harbour, NSW, Australia.
ORCID-Profile: Kate Summer, Qi Guo
Förderung
- Southern Cross University
- Malacological Society of Australasia
- Australian Research Council
- Australian Government Department of Education
Zitieren
APA
Summer, K., Guo, Q., Liu, L., Barkla, B., Giles, S., & Benkendorff, K. (2025). Antimicrobial proteins from oyster hemolymph improve the efficacy of conventional antibiotics. PLOS ONE, 20(1), e0312305. https://doi.org/10.1371/journal.pone.0312305
Vancouver
Summer K, Guo Q, Liu L, Barkla B, Giles S, Benkendorff K. Antimicrobial proteins from oyster hemolymph improve the efficacy of conventional antibiotics. PLOS ONE. 2025;20(1):e0312305. doi:10.1371/journal.pone.0312305
BibTeX
@article{Summer2025,
author = {Summer, Kate and Guo, Qi and Liu, Lei and Barkla, Bronwyn and Giles, Sarah and Benkendorff, Kirsten},
title = {Antimicrobial proteins from oyster hemolymph improve the efficacy of conventional antibiotics},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {1},
pages = {e0312305},
doi = {10.1371/journal.pone.0312305}
}
EUVIMED